(Q34359341)
Statements
1 reference
FDA approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements (English)
1 reference
Dickran Kazandjian
1 reference
Gideon M Blumenthal
1 reference
Huan-Yu Chen
1 reference
Kun He
1 reference
Mona Patel
1 reference
Robert Justice
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
28 August 2014
1 reference
1 reference
19
1 reference
10
1 reference
e5-11
1 reference
Identifiers
1 reference
1 reference
1 reference